Inverted Flap Versus Internal Limiting Membrane Peeling in Small Full Thickness Macular Holes
NCT ID: NCT04498624
Last Updated: 2020-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2020-05-01
2021-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ILM Peeling Versus Inverted Flap Technique for Treatment of Macular Hole: Near Visual Acuity Outcomes
NCT04698226
Internal Limiting Membrane Peeling for Large Macular Holes
NCT00190190
Foveal Sparing of the ILM
NCT03488576
Foveal Sparing ILM Peeling With ILM Flap Transposition
NCT05897671
Inverted Internal Limiting Membrane Flap Technique for Macular Hole Retinal Detachment in Highly Myopic Eyes
NCT02896972
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
inverted flap
inverted flap
full thickness macular hole surgery
peeling internal limiting membrane (ILM)
peeling internal limiting membrane (ILM)
full thickness macular hole surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
inverted flap
full thickness macular hole surgery
peeling internal limiting membrane (ILM)
full thickness macular hole surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* idiopathic full thickness macular hole ≤ 350 micron of diameter
* phakic or pseudophakic
* absence of systemic adverse conditions
Exclusion Criteria
* previous ocular surgery except cataract surgery
* axial length \>26mm
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Turin, Italy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michele Reibaldi
Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
A.O.U. Città della Salute e della Scienza di Torino
Torino, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
MIchele Reibaldi, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Ventre L, Fallico M, Longo A, Parisi G, Russo A, Bonfiglio V, Marolo P, Caselgrandi P, Avitabile T, Borrelli E, Reibaldi M. CONVENTIONAL INTERNAL LIMITING MEMBRANE PEELING VERSUS INVERTED FLAP FOR SMALL-TO-MEDIUM IDIOPATHIC MACULAR HOLE: A Randomized Trial. Retina. 2022 Dec 1;42(12):2251-2257. doi: 10.1097/IAE.0000000000003622. Epub 2022 Sep 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0062156
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.